Is YKL-40 a new therapeutic target in cancer?

Author： Johansen Julia S   Jensen Benny Vittrup   Roslind Anne   Price Paul A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.2, 2007-02, pp. : 219-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 702-718

Bentham Science Publishers

Access to resources Recommend Favorite

YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer

By Peng C   Peng J   Jiang L   You Q   Zheng J   Ning X  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1448-1457

Field House Publishing

Access to resources Recommend Favorite

Akt as a therapeutic target in cancer

By Steelman Linda S   Stadelman Kristin M   Chappell William H   Horn Stefan   Bäsecke Jörg   Cervello Melchiorre   Nicoletti Ferdinando   Libra Massimo   Stivala Franca   Martelli Alberto M   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1139-1165

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis as a therapeutic target in cancer

By Kumaran Gireesh   Clamp Andrew R   Jayson Gordon C  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 455-458

Royal College Of Physicians

Access to resources Recommend Favorite

Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 482-496

Bentham Science Publishers

Access to resources Recommend Favorite